KAYSEN DAVID B 4
4 · UROPLASTY INC · Filed Aug 5, 2011
Insider Transaction Report
Form 4
KAYSEN DAVID B
President, CEO
Transactions
- Purchase
common stock
2011-08-02$6.57/sh+1,500$9,855→ 57,500 total
Holdings
- 300,000
employee non-qualified stock options
Exercise: $2.50From: 2006-05-17Exp: 2016-05-16→ Common Stock (300,000 underlying) - 50,000
employee non-qualified stock options
Exercise: $4.31From: 2007-07-03Exp: 2012-07-02→ Common Stock (50,000 underlying) - 100,000
employee non-qualified stock options
Exercise: $0.85From: 2009-06-05Exp: 2014-06-04→ Common Stock (100,000 underlying) - 26,075
employee non-qualified stock options
Exercise: $4.94From: 2011-06-08Exp: 2017-06-07→ Common Stock (26,075 underlying) - 16,350
employee non-qualified stock options
Exercise: $7.98From: 2012-06-07Exp: 2018-06-06→ Common Stock (16,350 underlying) - 50,000
employee non-qualified stock options
Exercise: $3.15From: 2008-06-24Exp: 2013-06-23→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Includes 15,225 shares of restricted stock that vests with respect to one third of the shares on the second, third and fourth anniversaries of the grant date (June 8, 2010) and 12,550 shares of restricted stock that vests with respect to one fourth of the shares on the first, second, third and fourth anniversaries of the grant date (June 7, 2011)
- [F2]Becomes exercisable with respect to one-third of the shares on such date, and an additional, cumulative one-third on the first and second anniversary of such date.